ACME Lithium Inc.: ACME Lithium to Acquire Clayton Valley Nevada Lithium Brine Project
ACME Lithium Inc. (
CSE: ACME) (the Company , or ACME ) is pleased to announce that the Company has entered into an option agreement ( Option ) with GeoXplor Corporation ( GeoXplor ) to acquire a 100% interest in 64 claims encompassing approximately 1,280 acres, comprising the CC, CCP and SX placer lithium claims (the Project Claims ), located in Clayton Valley, Esmeralda County, Nevada - the centre of lithium development in the United States.
The Project Claims are contiguous to the south with the only lithium brine production operation in North America, NYSE-listed Albemarle s Silver Peak Lithium mine, which has been in production since 1966. In addition, the Project claims are contiguous with Pure Energy Minerals joint venture with Schlumberger Technology Corporation to the east. The Project Claims are located on the north western part of Clayton Valley about 20 miles northwest of the cou
New Consultancy Agreement and Related Party Transaction Agronomics, a leading listed company in alternative proteins with a focus on cellular agriculture and cultivated meat, announces that it has agreed revised terms of its consultancy agreement with Shellbay Limited ( Shellbay ), principally concerning the fee arrangements in connection with the provision of consultancy services to the Company by Shellbay. Background to and reasons for the changes to the agreement The Company has since 2011 had a consulting agreement with Shellbay which is owned by Mr Jim Mellon, Director and 22.75% shareholder in the Company, as reported annually in the Company s Report and Accounts. In December 2019, following shareholder feedback and in consultation with the Company s advisers, the terms of this agreement were altered for the subsequent 12 months on the basis that from January 2021 new arrangements would be put in place to (i) ensure the terms of Shellbay s
Andean Precious Metals Corp.: Andean Precious Metals Announces Engagement of Investor Relations Provider
Andean or the
Company ), a precious metals production, development and exploration company headquartered in Toronto, Ontario, is pleased to announce that it has retained Hybrid Financial Ltd. (
Hybrid ) to perform marketing services for the Company (the
Services ). Hybrid has been engaged to heighten market and brand awareness for Andean and to broaden Andean s reach within the investment community through various channels including, but not limited to, direct telephone and e-mail marketing.
The Company has engaged Hybrid for an initial period of six months starting on May 4, 2021 (the
Pancontinental Resources Corporation: Pancon Reports Significant Copper in Discovery Holes 4 and 5
Toronto, Ontario (Newsfile Corp. - April 27, 2021) - Pancontinental Resources Corporation (TSXV: PUC) (OTCQB: PUCCF) ( Pancon or the Company ), further to its news release of March 2, 2021, reports complete gold assay and multielement geochemistry results for diamond holes 1 through 5, among the total 7 diamond and 2 sonic holes drilled in Phase 1 of the Company s fully funded 10,000-meter (m) maiden diamond drill program at its flagship Brewer Gold & Copper Project (see Table 1). Results for diamond holes 6 and 7 and sonic holes 1 and 2 are pending. The Brewer Project, on the gold-rich Carolina Slate Belt in South Carolina, is where the former shallow Brewer Gold Mine produced 178,000 ounces of oxide gold between 1987-1995, and is located 12 kilometers along trend from the producing Haile Gold Mine.
BriaCell Announces Investor and Media Outreach Programs
BriaCell Therapeutics Corp. a clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast cancer, announces that it has recently expanded its investor and media outreach platform in order to enhance communication with investors and increase investor awareness of and interest in the Company, its product candidates, and its clinical programs. The comprehensive program is expected …
BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V:BCT) (“BriaCell” or the “Company”) a clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast cancer, announces that it has recently expanded its investor and media outreach platform in order to enhance communication with investors and increase investor awareness of and interest in the Company, its product candidates, and its clinical programs. The comprehensive program is expected to enhance BriaCell’s di